Kodiak Sciences (KOD) EPS (Weighted Average and Diluted) (2020 - 2026)

Kodiak Sciences filings provide 7 years of EPS (Weighted Average and Diluted) readings, the most recent being -$0.94 for Q1 2026.

  • Quarterly EPS (Weighted Average and Diluted) rose 13.76% to -$0.94 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$4.17 through Mar 2026, down 14.88% year-over-year, with the annual reading at -$4.32 for FY2025, 28.96% down from the prior year.
  • EPS (Weighted Average and Diluted) hit -$0.94 in Q1 2026 for Kodiak Sciences, up from -$1.04 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.82 in Q1 2024 and bottomed at -$1.83 in Q1 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$1.17, with a median of -$1.09 recorded in 2025.
  • The largest annual shift saw EPS (Weighted Average and Diluted) plummeted 61.11% in 2022 before it skyrocketed 43.79% in 2024.
  • Kodiak Sciences' EPS (Weighted Average and Diluted) stood at -$1.35 in 2022, then rose by 16.3% to -$1.13 in 2023, then increased by 25.66% to -$0.84 in 2024, then dropped by 23.81% to -$1.04 in 2025, then grew by 9.62% to -$0.94 in 2026.
  • Per Business Quant, the three most recent readings for KOD's EPS (Weighted Average and Diluted) are -$0.94 (Q1 2026), -$1.04 (Q4 2025), and -$1.16 (Q3 2025).